Demographics (1)
- Sex - Gender of participant (phv00273661.v1.p1)
Disease Events (1)
- Age_onset - Disease onset age (phv00273662.v1.p1)
Other (19)
- AFFECTION_STATUS - Case control status of the subject for melanoma tumor (phv00273653.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00273665.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00273650.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00273667.v2.p1)
- IS_TUMOR - Tumor status (phv00273666.v2.p1)
- Response - Response upon anti-CTLA4 treatment or IFNg-stimulation (phv00273660.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00273663.v2.p1)
- SAMPLE_ID - Sample ID (phv00273655.v2.p1)
- SAMPLE_SOURCE - Source repository where samples originate (phv00273656.v2.p1)
- SAMPLE_TYPE - What type of sample was collected (phv00273664.v2.p1)
- SAMPLE_USE - Sample Use (phv00273658.v2.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00273669.v2.p1)
- SOURCE_SAMPLE_ID - Sample ID used in the source repository (phv00273657.v2.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the source repository (phv00273652.v1.p1)
- SUBJECT_ID - Subject ID (phv00273649.v1.p1)
- SUBJECT_ID - Subject ID (phv00273654.v2.p1)
- SUBJECT_ID - De-identified Subject ID (phv00273659.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00273651.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00273668.v2.p1)